FDx Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,306
| Closed | -$1.01M | – | 670 |
|
|
2023
Q4 | $1.01M | Buy |
8,306
+3,865
| +87% | +$431K | 0.08% | 252 |
|
|
2023
Q3 | $498K | Buy |
4,441
+2,923
| +193% | +$371K | 0.04% | 347 |
|
|
2023
Q2 | $221K | Sell |
1,518
-339
| -18% | -$46.1K | 0.01% | 690 |
|
|
2023
Q1 | $237K | Hold |
1,857
| – | – | 0.01% | 650 |
|
|
2022
Q4 | $237K | Buy |
+1,857
| New | +$215K | 0.01% | 650 |
|
|
2022
Q3 | – | Sell |
-3,595
| Closed | -$378K | – | 819 |
|
|
2022
Q2 | $378K | Sell |
3,595
-560
| -13% | -$66.4K | 0.01% | 555 |
|
|
2022
Q1 | $531K | Buy |
4,155
+1,379
| +50% | +$166K | 0.02% | 486 |
|
|
2021
Q4 | $342K | Sell |
2,776
-2,783
| -50% | -$364K | 0.01% | 658 |
|
|
2021
Q3 | $790K | Buy |
5,559
+379
| +7% | +$55.8K | 0.03% | 384 |
|
|
2021
Q2 | $809K | Buy |
5,180
+1,475
| +40% | +$239K | 0.03% | 378 |
|
|
2021
Q1 | $576K | Buy |
+3,705
| New | +$574K | 0.02% | 431 |
|
|
2019
Q3 | – | Sell |
-2,892
| Closed | -$331K | – | 829 |
|
|
2019
Q2 | $331K | Buy |
2,892
+511
| +21% | +$59.9K | 0.01% | 603 |
|
|
2019
Q1 | $295K | Buy |
+2,381
| New | +$271K | 0.01% | 605 |
|
|
2018
Q4 | – | Sell |
-3,145
| Closed | -$401K | – | 847 |
|
|
2018
Q3 | $401K | Sell |
3,145
-35
| -1% | -$4.16K | 0.01% | 591 |
|
|
2018
Q2 | $344K | Sell |
3,180
-11,105
| -78% | -$1.21M | 0.01% | 673 |
|
|
2018
Q1 | $1.51M | Sell |
14,285
-212
| -1% | -$24.6K | 0.05% | 368 |
|
|
2017
Q4 | $1.7M | Sell |
14,497
-391
| -3% | -$44.2K | 0.05% | 365 |
|
|
2017
Q3 | $1.69M | Sell |
14,888
-3,014
| -17% | -$348K | 0.05% | 367 |
|
|
2017
Q2 | $2.23M | Buy |
17,902
+2,070
| +13% | +$245K | 0.07% | 267 |
|
|
2017
Q1 | $1.88M | Sell |
15,832
-79
| -0.5% | -$8.95K | 0.06% | 297 |
|
|
2016
Q4 | $1.59M | Buy |
15,911
+2,034
| +15% | +$218K | 0.05% | 351 |
|
|
2016
Q3 | $1.75M | Sell |
13,877
-3,922
| -22% | -$485K | 0.07% | 238 |
|
|
2016
Q2 | $2.08M | Buy |
17,799
+1,620
| +10% | +$183K | 0.09% | 193 |
|
|
2016
Q1 | $1.68M | Sell |
16,179
-532
| -3% | -$51.5K | 0.08% | 232 |
|
|
2015
Q4 | $1.66M | Buy |
16,711
+4,307
| +35% | +$421K | 0.08% | 231 |
|
|
2015
Q3 | $1.13M | Sell |
12,404
-432
| -3% | -$43.3K | 0.1% | 212 |
|
|
2015
Q2 | $1.36M | Buy |
12,836
+785
| +7% | +$86.9K | 0.07% | 262 |
|
|
2015
Q1 | $1.37M | Sell |
12,051
-781
| -6% | -$89.1K | 0.03% | 468 |
|
|
2014
Q4 | $1.41M | Buy |
12,832
+66
| +0.5% | +$6.96K | 0.09% | 218 |
|
|
2014
Q3 | $1.25M | Sell |
12,766
-49
| -0.4% | -$4.82K | 0.08% | 264 |
|
|
2014
Q2 | $1.29M | Sell |
12,815
-29
| -0.2% | -$2.83K | 0.08% | 260 |
|
|
2014
Q1 | $1.18M | Buy |
12,844
+4,254
| +50% | +$392K | 0.1% | 206 |
|
|
2013
Q4 | $777K | Buy |
8,590
+1,167
| +16% | +$101K | 0.08% | 252 |
|
|
2013
Q3 | $592K | Buy |
7,423
+3,082
| +71% | +$243K | 0.07% | 259 |
|
|
2013
Q2 | $316K | Buy |
+4,341
| New | +$325K | 0.04% | 370 |
|
Other funds holding ZBH
FDx Advisors's ZBH Position: Q1 2024 in Review
FDx Advisors sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 8,306 shares — an estimated $1.01M sold.
FDx Advisors first reported a position in ZBH in Q2 2013 and held it in 35 quarters. The position peaked at $2.23M in Q2 2017. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- FDx Advisors reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
- FDx Advisors sold 8,306 Zimmer Biomet shares in Q1 2024, an estimated $1.01M.
- FDx Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 35 quarters.
- FDx Advisors's Zimmer Biomet position peaked at $2.23M in Q2 2017.
- 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.